4
12. Ghandi, M.; Olyaei, A.; Salimi, F. Synth. Commun. 2007, 37, 247.
H2N NH2
NH2Cl
NH2
N
13. Ghandi, M.; Olyaei, A. J. Heterocycl. Chem. 2007, 44, 323.
14. Ghandi, M.; Salimi, F.; Olyaei, A. J. Heterocycl. Chem, 2006, 43,
791.
15. Caterina, M. C.; Perillo, I. A.; Boiani, L.; Pezaroglo, H.;
Cerecetto, H.; González, M.; Salerno, A. Bioorg. Med. Chem.
2008, 16, 2226.
H
H
N
N
N
N
N
2
CH2O (aq) +
N
N
solvent-free
120 oC
16. Sharma, V.; Khan, M. S. Eur. J. Med. Chem. 2001, 36, 651.
17. Sharma, V.; Crankshaw, C. L.; Piwnica-Worms, D. J. Med. Chem.
1996, 39, 3483.
18. Sage, C. R.; Michelitsch, M. D.; Stout, T. J.; Biermann, D.;
Nissen, R.; Finer-Moore, J.; Stroud, R. M. Biochemistry 1998, 37,
13893.
O
O
HO
OH
N
(aq)
N
N N
H
H
N
N
80 oC
19. Crank, G.; Harding, D. R. K.; Szinai, S. S. J. Med. Chem. 1970,
13, 1212.
4j
Scheme 3. One-pot synthesis of imidazolidine 4j
20. (a) Shockravi, A.; Sadeghpour, M. Olyaei, A. J. Chem. Res. 2009,
656; (b) Shockravi, A.; Sadeghpour, M.; Olyaei, A. Synth.
Commun. 2010, 40, 2531; (c) Olyaei, A.; Raufmoghaddam, S.;
Sadeghpour, M.; Ebadzadeh, B. Chin. J. Chem. 2010, 28, 825; (d)
Olyaei, A.; Shams, B.; Sadeghpour, M.; Gesmati, F.; Razaziane,
Z. Tetrahedron Lett. 2010, 51, 6086; (e) Olyaei, A.; Zarnegar, M.;
Sadeghpour, M.; Rezaei, M. Lett. Org. Chem. 2012, 9, 451; (f)
Olyaei, A.; Vaziri M.; Razeghi, R. Tetrahedron Lett. 2013, 54,
1963.
In summary, to the best of our knowledge, this Letter
describes the first report on the stereoselective synthesis of novel
trans-4,5-dihydroxy-2-aryl-1,3-bis(heteroaryl)imidazolidines via
the reaction of heteroaryl amines, aryl aldehydes and glyoxal.
The advantages of the present method are high efficiency and
generality, clean reaction profiles and the two-step synthetic
sequence can be carried out without isolation of the intermediate.
This leads to a reduction in the overall reaction time and energy
requirements, and constitutes an economical method for
preparing new imidazolidine compounds.
21. General procedure for the synthesis of imidazolidines (4): A
mixture of heteroarylamine (2 mmol), aldehyde (1 mmol) and
o
guanidinium chloride (0.1 mmol) was heated at 120 C for 15-70
min (Table 1), in an oil-bath under solvent-free conditions. Upon
completion, as monitored by TLC, the mixture was cooled to 80
oC, then glyoxal (40% aqueous solution, 1 mmol) was added and
the mixture stirred at the same temperature for 5-15 min as
indicated in Table 1. After completion, the mixture was cooled to
room temperature and EtOH (5 mL) was added until solid
products precipitated. The precipitate was filtered, washed with
EtOH and dried. The crude product was purified by column
chromatography on silica gel (n-hexane/EtOAc, 30/70) to afford
the corresponding pure white products 4. 4,5-Dihydroxy-2-phenyl-
Acknowledgments
The authors thank the Research Council of Payame Noor
University for financial support.
Supplementary data
o
1,3-bis(2-pyrimidinyl)imidazolidine (4a): m.p. = 201-202 C; IR
1
(KBr): 3120, 2946, 1585, 1454, 1319, 1272, 1041 cm-1; H NMR
Supplementary data (1H and 13C NMR, MS, CHN and IR)
associated with this article can be found, in the online version.
(400 MHz, DMSO-d6): δ: 5.93 (m, 2H, CH-OH), 6.23 (d, 1H, J =
6.0 Hz, OH), 6.52 (d, 1H, J = 3.6 Hz, OH), 6.71 (s, 1H, CH), 6.74
(t, 1H, J = 4.8 Hz, pyrimidinyl-H5), 6.77 (t, 1H, J = 4.8 Hz,
pyrimidinyl-H5'), 7.11-7.82 (m, 5H, phenyl-H), 8.35 (d, 2H, J =
4.8 Hz, pyrimidinyl-H4,6), 8.42 (d, 2H, J = 4.8 Hz, pyrimidinyl-
H4',6') ppm; 13C NMR (100 MHz, DMSO-d6): δ: 74.35, 85.63,
85.93, 112.36, 112.65, 127.42, 127.50, 129.62, 141.71, 158.13,
158.37, 158.83, 159.34 ppm; MS (EI): m/z 336 (M+), 319, 277,
213, 201, 184, 124, 106, 96, 79; Anal. calcd. for C17H16N6O2: C,
60.71; H, 4.76; N, 25.00. Found: C, 60.80; H, 4.70; N, 25.09. 4,5-
Dihydroxy-2-(4-chlorophenyl)-1,3-bis(4-methyl-2-pyrimidinyl)
References and notes
1. Vail, S. L.; Moran, C. M.; Moor, H. B.; Kullman, R. M. H. J. Org.
Chem. 1962, 27, 2071.
2. Alexakis, A.; Tranchier, J. P.; Lensen, N.; Mangeney, P. J. Am.
Chem. Soc. 1995, 117, 10767.
3. Willer, R. L.; Moore, D. W.; Vanderah, D. J. J. Org. Chem. 1985,
50, 2365.
4. Koppes, W. M.; Chaykovsky, M.; Adolph, H. J.; Gilardi, R. D.;
George, C. F. J. Org. Chem. 1987, 52, 1113.
o
imidazolidine (4e): m.p. = 194-196 C; IR (KBr): 3178, 2962,
1
1569, 1450, 1253, 1041 cm-1; H NMR (400 MHz, DMSO-d6): δ:
2.25 (s, 3H, CH3), 2.32 (s, 3H, CH3), 5.88 (m, 2H, CH-OH), 6.17
(br s, 1H, OH), 6.51 (br s, 1H, OH), 6.62 (s, 1H, CH), 6.64 (d,
1H, J = 5.2 Hz, pyrimidinyl-H5), 6.66 (d, 1H, J = 5.2 Hz,
pyrimidinyl-H5'), 7.27 (d, 2H, J = 8.4 Hz, phenyl-H), 7.82 (d, 2H,
J = 8.4 Hz, phenyl-H), 8.25 (m, 2H, pyrimidinyl-H6,6') ppm; 13C
NMR (100 MHz, DMSO-d6): δ: 24.05, 24.20, 73.84, 85.47, 85.62,
111.80, 112.21, 127.34, 131.73, 141.18, 157.55, 157.94, 158.56,
159.11 ppm; MS (EI): m/z 400 (M+2)+, 398 (M+), 341, 339, 234,
232, 138, 110, 93, 66; Anal. calcd. For C19H19ClN6O2: C, 57.28;
H, 4.77; N, 21.10. Found: C, 57.34; H, 4.79; N, 21.14.
5. Ferguson, I. J.; Katritzky, A. R.; Patel, R. J. Chem. Soc., Perkin
Trans. 2, 1976, 1564.
6. Dunnavant, W. R.; James, F. L. J. Am. Chem. Soc. 1956, 78, 2740.
7. Nematollah, J.; Ketcham, R. J. Org. Chem. 1963, 28, 2378.
8. Frick, J. G.; Harper, R. G. Ind. Eng. Chem. Prod. Res. Dev. 1982,
21, 599.
9. Cort, L. A.; Francis, N. R. J. Chem. Soc. 1964, 2799.
10. Willer, R. L.; Moore, D. W.; Lowe-Ma, C. K.; Vanderah, D. J. J.
Org. Chem. 1985, 50, 2368.
11. Nielsen, A. T.; Nissan, R. A.; Chafin, A. P.; Gilardi, R. D.;
George, C. F. J. Org. Chem. 1992, 57, 6756.